Skip to main content
ACT
NASDAQ Finance

Enact Q3 EPS $1.15 Misses; Loss Ratio Jumps to 20%, Dividend Raised to $0.24

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Negative
Importance info
7
Price
$48.24
Mkt Cap
$6.632B
52W Low
$35.49
52W High
$50.56
52W Position info
36% above low
Off High info
4.6% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

ACT sits 36% above its 52-week low of $35.49.

Summary

Enact reported Q3 net income of $159 million ($1.15 per share), missing the $1.25 consensus, as the loss ratio jumped to 20% from 14%. It declared a $0.24 dividend and raised full-year 2026 capital return guidance to about $600 million.


Key Events · Earnings and Guidance · ACT

  • Q3 EPS Misses Consensus

    Net income of $159 million, or $1.15 per diluted share, versus $1.25 in Q2 2026 and $1.10 a year ago; adjusted operating income was $164 million, or $1.19 per share.

  • Loss Ratio Jumps to 20%

    Losses incurred rose to $47 million from $33 million sequentially, and the loss ratio climbed to 20% from 14%, on higher new delinquencies and a $37 million reserve release versus $37 million and $45 million in the prior periods.

  • Dividend and Capital Return Raised

    Board declared a $0.24 per share dividend payable December 17, 2026 to holders of record November 25, 2026, and full-year 2026 capital return guidance was lifted to approximately $600 million.

  • PMIERs Cushion Slips to 158%

    PMIERs sufficiency fell to 158%, or $1.8 billion above requirements, from 161% and $1.9 billion, primarily reflecting the $200 million EMICO dividend to EHI.


Analysis · ACT · Finance

Enact earned $159 million, or $1.15 per diluted share, down from $1.25 last quarter and short of the $1.25 consensus the press flagged. Credit is the bigger story: losses incurred nearly doubled sequentially to $47 million, and the loss ratio jumped to 20% from 14% on higher new delinquencies and thinner reserve releases ($37 million this quarter). Capital return remains the offset. The board declared a $0.24 dividend, and management lifted full-year 2026 capital return guidance to roughly $600 million, backed by $1.8 billion of PMIERs excess capital at a 158% sufficiency ratio. With the stock near its 52-week high, the loss-ratio deterioration is the item most likely to reset expectations.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ACT was trading at $48.24 on NASDAQ in the Finance sector, with a market capitalization of approximately $6.6B. The 52-week trading range was $35.49 to $50.56. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ACT - Latest Insights

ACT
Nov 09, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $47.80
Real-time Price: $44.19 info
Change: -$3.61 (-8%) info
Market Cap: $5.941B info
ACT
Nov 05, 2026, 4:19 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $47.77
Real-time Price: $44.19 info
Change: -$3.58 (-7%) info
Market Cap: $5.941B info
ACT
Nov 04, 2026, 4:20 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $48.24
Real-time Price: $44.19 info
Change: -$4.05 (-8%) info
Market Cap: $5.941B info
ACT
Aug 06, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $48.67
Real-time Price: $44.19 info
Change: -$4.48 (-9%) info
Market Cap: $5.941B info
ACT
Aug 05, 2026, 4:23 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $47.83
Real-time Price: $44.19 info
Change: -$3.64 (-8%) info
Market Cap: $5.941B info